Rusia invadió Ucrania el 24 de febrero de 2022. Apoye a Ucrania y ayúdenos a luchar por la libertad y la democracia en Europa.  Apoye a Ucrania!  Únasenos
search
Plataforma de Turismo Médico #1 desde 2014

S Eroglu

Otorrinolaringológo

12 años de experiencia

Dr. S Eroglu is a medical professional, specializing in several fields, including Septoplasty and Nasal polyp surgery. Dr. Eroglu's professional journey is characterized by involvement in clinical trials and research, especially in targeted therapies and combination immunotherapeutics for melanoma. The doctor has also focused on improving opioid delivery in an inpatient setting and has led a successful Quality Improvement project in this area. Dr. Eroglu has contributed to numerous medical publications.

Ubicación

Descubre los paquetes más populares de la temporada

clinic image
clinic image clinic image
Toque para ver más sobre el paquete
Turquía, Estambul
C L I N I S T A ® Hair Clinic
Paquete Standard. Rinoplastia (cirugía de nariz) Todo incluido
Nueva clínica
Paquetes Todo Incluido

Dr. S Eroglu is a dedicated medical professional, deeply involved in clinical trials, research, and the creation of personalized treatment strategies. The doctor specializes in procedures like Septoplasty and Nasal polyp surgery, among others, and has led successful initiatives to enhance health care delivery systems.

Education

  • Dr. Eroglu earned an MD degree and is board certified in Internal Medicine - Medical Oncology. The doctor completed a residency in Internal Medicine at the University of California, Irvine, and a fellowship in Hematology/Oncology at the City of Hope/Harbor-UCLA Medical Center.

Awards

  • Dr. Eroglu's Quality Improvement (QI) project focused on improving the delivery of opioids in an inpatient setting and was selected as the winning QI project by the American College of Physicians (ACP).

Publications

  • Dr. Eroglu has contributed to diverse publications, with topics encompassing the efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy and circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.